|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/145 | |||
| A61K 39/385 | |||
| C07H 3/00 | |||
| C12N 7/00 | |||
| A61K 39/095 | |||
| A61K 39/102 |
| (11) | Number of the document | 2283857 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10177832.2 |
| Date of filing the European patent application | 2006-06-23 | |
| (97) | Date of publication of the European application | 2011-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0513071 | 2005-06-27 | GB | |
| 0513069 | 2005-06-27 | GB | |
| 0515556 | 2005-07-28 | GB | |
| 0524204 | 2005-11-28 | GB | |
| 0526040 | 2005-12-21 | GB | |
| 0526041 | 2005-12-21 | GB |
| (72) |
Biemans, Ralph, BE
Boutriau, Dominique, BE
Capiau, Carine, BE
Denoel, Philippe, BE
Duvivier, Pierre, BE
Poolman, Jan, BE
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | Vaccine composition comprising conjugated native N. Meningitidis capsular polysaccharides |
| Vaccine composition comprising conjugated native N. Meningitidis capsular polysaccharides |